Genetic Factors Affecting DHEAS Levels and Reproductive Health

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on hormones & fertility. Browse all Hormones & Fertility education

DHEAS (dehydroepiandrosterone sulfate) is the most abundant circulating steroid hormone in the human body, and it sits upstream of both testosterone and estrogen. Because it acts as a reservoir the body draws on to build downstream sex hormones, DHEAS levels have a real bearing on reproductive health, energy, libido, and how the body ages. Those levels are not set by lifestyle alone — several named genes shape how much DHEAS you make and how quickly you clear it.

What DHEAS Is and Why It Matters for Reproductive Health

DHEAS is produced mainly by the zona reticularis of the adrenal glands, with a smaller contribution from the gonads. Cells convert cholesterol into DHEA, then attach a sulfate group to create the more stable, longer-lasting DHEAS. Peripheral tissues can reverse that step and funnel DHEA into androgens and estrogens as needed.

In women, DHEAS contributes to ovarian follicle health, libido, and androgen balance; unusually high levels are often flagged during workups for polycystic ovary syndrome (PCOS) or adrenal conditions. In men, it feeds the broader androgen pool. In both sexes, DHEAS peaks in the twenties and declines steadily with age — a pattern sometimes called adrenopause.

The Genes That Shape DHEAS Production

Two enzymes do the heavy lifting. CYP17A1 (17α-hydroxylase/17,20-lyase) controls the branch point where the adrenal gland commits cholesterol toward androgen synthesis. Common variants such as rs743572 in CYP17A1 have been studied for their association with androgen levels and PCOS risk.

The second key gene is SULT2A1, the sulfotransferase that converts DHEA into DHEAS. Genome-wide association studies have repeatedly linked variants near SULT2A1 — including rs2637125 — to circulating DHEAS concentrations. A person carrying a lower-activity SULT2A1 variant may sulfate DHEA less efficiently, shifting the balance between the active hormone and its storage form.

What the Research Shows About DHEAS-Related Variants

Large population studies have mapped at least eight genomic regions associated with DHEAS levels, including loci near SULT2A1, ZKSCAN5, ARPC1A, TRIM4, and HHEX. These findings suggest that a meaningful share of the person-to-person variation in DHEAS is heritable rather than purely behavioral.

Importantly, carrying a variant tied to higher or lower DHEAS is not a diagnosis. It describes a tendency in a biological pathway — one input among many that a clinician weighs alongside blood work, symptoms, and medical history.

DHEAS Across the Reproductive Lifespan

Because DHEAS supplies the raw material for sex hormones, its trajectory intersects with fertility, cycle regularity, and the menopausal transition. Some fertility specialists monitor DHEAS in the context of ovarian reserve, while endocrinologists track it when evaluating androgen excess. The genetic factors above help explain why two people with similar diets and activity levels can show very different DHEAS readings.

Understanding your genetic tendency does not replace hormone testing, but it can add context to the numbers and give you sharper questions to bring to a qualified provider.

What Pathway-Level Genetic Insight Can and Cannot Tell You

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in hormone- and androgen-related pathways where genes like SULT2A1 and CYP17A1 operate. It reports on your biology at the pathway level — how your genes may influence steroid-hormone processing — not on any diagnosis, and not on what any specific supplement or medication will do for you.

That distinction matters. PlexusDx tells you about your biology; it does not tell you what to put in your body. Genetics is a guide, not a guarantee, and any decision about DHEAS, hormone support, or fertility care belongs in a conversation with your healthcare provider.

Frequently Asked Questions

What causes high DHEAS levels?

High DHEAS usually reflects increased adrenal androgen production and is often evaluated in the context of PCOS or adrenal conditions. Genetics plays a role: variants in genes like CYP17A1 and SULT2A1 influence how much DHEAS you make and store. A provider interprets levels alongside symptoms and additional lab work.

Does DHEAS affect fertility?

DHEAS supplies precursor material for estrogen and testosterone, so it intersects with reproductive function in both sexes. Some fertility specialists monitor it during ovarian-reserve evaluations. It is one input among many, and abnormal levels warrant a professional workup rather than self-directed interpretation.

Can a genetic test diagnose a hormone disorder?

No. A genetic test describes tendencies in biological pathways, such as steroid-hormone processing, not a diagnosis. The PlexusDx Precision Peptide Genetic Test offers pathway-level context about your DNA. Diagnosing any hormone condition requires clinical evaluation and blood testing ordered by a qualified provider.

Why do DHEAS levels drop with age?

DHEAS peaks in early adulthood and declines gradually thereafter as adrenal output shifts, a pattern sometimes called adrenopause. The rate of decline varies between individuals, influenced partly by inherited differences in the genes that govern adrenal androgen synthesis and sulfation.

Curious how your genes influence hormone-related pathways? Explore the Precision Peptide Genetic Test to understand your biology at the pathway level before making any decisions with your provider.

This article is part of the PlexusDx Education Hub. Browse all Hormones & Fertility education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.